Effects of genetic and nongenetic factors on total and bioavailable 25(OH)D responses to Vitamin D supplementation

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 1, 2017, Pages 100-110

  Yao, Pang ^a   Sun, Liang ^a   Lu, Ling ^a   Ding, Hong ^c   Chen, Xiafei ^d   Tang, Lixin ^d   Xu, Xinming ^e   Liu, Gang ^a   Hu, Yao ^a   Ma, Yiwei ^a   Wang, Feijie ^a   Jin, Qianlu ^a   Zheng, He ^a   Yin, Huiyong ^a   Zeng, Rong ^b   Chen, Yan ^a   Hu, Frank B ^f   Li, Huaixing ^a   Lin, Xu ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

^d HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL; CALCIUM; CYTOCHROME P450; CYTOSINE; GUANINE; PARATHYROID HORMONE; PLACEBO; PROTEIN CYP2R1; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CHINESE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DIETARY SUPPLEMENT; FOLLOW UP; GENETICS; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CALCIUM; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; PARATHYROID HORMONE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 85010527289     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-2930     Document Type: Article

References (47)

1. Holick MF.VitaminDdeficiency.NEnglJMed. 2007; 357(3):266-281.
2. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009; 32(7):1278-1283.
3. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B. A pooled analysis of vitamin D dose requirements for fracture prevention [published correction appears in N Engl J Med. 2012; 367(5):481]. N Engl J Med. 2012; 367(1):40-49.
4. Dobnig H, Pilz S, Scharnagl H, RennerW, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168(12):1340-1349.
5. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004; 79(3):362-371.
6. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-1930.
7. Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, Kestenbaum BR, de Boer IH. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013; 310(2):179-188.
8. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitaminDfor adult and elderly men and women. Am J Clin Nutr. 2004; 80(6, Suppl)1763S-1766S.
9. Awumey EMK, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the southern United States: A clinical research center study. J Clin Endocrinol Metab. 1998; 83(1):169-173.
10. Gutiérrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011; 22(6):1745-1753.
11. Gallagher JC, Sai A, Templin T II, Smith L. Dose response to vitamin D supplementation in postmenopausal women: A randomized trial. Ann Intern Med. 2012; 156(6):425-437.
12. Ng K, Scott JB, Drake BF, Chan AT, Hollis BW, Chandler PD, Bennett GG, Giovannucci EL, Gonzalez-Suarez E, Meyerhardt JA, Emmons KM, Fuchs CS. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014; 99(3):587-598.
13. Yao P, Lu L, Hu Y, Liu G, Chen X, Sun L, Ye X, Zheng H, Chen Y, Hu FB, Li H, Lin X. A dose-response study of vitamin D3 supplementation in healthy Chinese: A 5-arm randomized, placebocontrolled trial. Eur J Nutr. 2016; 55(1):383-392.
14. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63(4):954-959.
15. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014; 144(Pt A):132-137.
16. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, Cooke NE. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999; 103(2):239-251.
17. Aloia J, Mikhail M, Dhaliwal R, Shieh A, Usera G, Stolberg A, Ragolia L, Islam S. Free 25(OH)D and the vitamin D paradox in AfricanAmericans. JClin EndocrinolMetab. 2015; 100(9):3356-3363.
18. Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-binding protein concentrations quantified by mass spectrometry. N Engl J Med. 2015; 373(15):1480-1482.
19. Nielson CM, Jones KS, Chun RF, Jacobs JM, Wang Y, Hewison M, Adams JS, Swanson CM, Lee CG, Vanderschueren D, Pauwels S, Prentice A, SmithRD, ShiT,Gao Y, SchepmoesAA,Zmuda JM, Lapidus J, Cauley JA, Bouillon R, Schoenmakers I, Orwoll ES; Osteoporotic Fractures inMen (MrOS) Research Group. Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations. J Clin Endocrinol Metab. 2016; 101(5):2226-2234.
20. Alzaman NS, Dawson-Hughes B, Nelson J, D'Alessio D, Pittas AG. Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. Am J Clin Nutr. 2016; 104(1):205-214.
21. Denburg MR, Hoofnagle AN, Sayed S, Gupta J, de Boer IH, Appel LJ, Durazo-Arvizu R, Whitehead K, Feldman HI, Leonard MB; Chronic Renal Insufficiency Cohort study investigators. Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Miner Res. 2016; 31(6):1128-1136.
22. Powe CE, EvansMK,Wenger J, Zonderman AB, Berg AH, NallsM, TamezH, ZhangD, Bhan I,Karumanchi SA, PoweNR, ThadhaniR. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21):1991-2000.
23. Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein (GC): A review of isoelectric focusing studies in human populations. Hum Genet. 1986; 72(4):281-293.
24. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010; 19(13):2739-2745.
25. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, Wolf M, Rice K, Goltzman D, Hidiroglou N, Ladouceur M, Wareham NJ, Hocking LJ, Hart D, Arden NK, Cooper C, Malik S, Fraser WD, Hartikainen AL, Zhai G, Macdonald HM, Forouhi NG, Loos RJ, Reid DM, Hakim A, Dennison E, Liu Y, Power C, Stevens HE, Jaana L, Vasan RS, Soranzo N, Bojunga J, Psaty BM, Lorentzon M, Foroud T, Harris TB, Hofman A, Jansson JO, Cauley JA, Uitterlinden AG, Gibson Q, Järvelin MR, Karasik D, Siscovick DS, Econs MJ, Kritchevsky SB, Florez JC, Todd JA, Dupuis J, Hyppönen E, Spector TD. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet. 2010; 376(9736):180-188.
26. Lu L, Sheng H, Li H, Gan W, Liu C, Zhu J, Loos RJ, Lin X. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Hum Genet. 2012; 131(3):505-512.
27. Shab-Bidar S, Bours S, Geusens PPMM, Kessels AGH, van den Bergh JPW. Serum 25(OH)D response to vitamin D3 supplementation: A meta-regression analysis. Nutrition. 2014; 30(9):975-985.
28. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of Creactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol. 2007; 49(17):1798-1805.
29. McGrath JJ, Saha S, Burne THJ, Eyles DW. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol. 2010; 121(1-2):471-477.
30. Bhan I, Powe CE, Berg AH, Ankers E, Wenger JB, Karumanchi SA, Thadhani RI. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012; 82(1):84-89.
31. Waterhouse M, Tran B, Armstrong BK, Baxter C, Ebeling PR, English DR, Gebski V, Hill C, Kimlin MG, Lucas RM, Venn A, Webb PM,Whiteman DC, Neale RE. Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adults. J Clin Endocrinol Metab. 2014; 99(7):E1332-E1340.
32. Naumova EN, Must A, Laird NM. Tutorial in biostatistics: evaluating the impact of "critical periods" in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol. 2001; 30(6):1332-1341.
33. Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK. Optimal vitaminDstatus and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr. 2006; 84(3):602-609.
34. Jemielita TO, Leonard MB, Baker J, Sayed S, Zemel BS, Shults J, Herskovitz R, Denburg MR. Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int. 2016; 27(2):617-626.
35. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96(1):53-58.
36. Aloia JF, Chen D-G, Chen H. The 25(OH)D/PTH threshold in black women. J Clin Endocrinol Metab. 2010; 95(11):5069-5073.
37. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF, Zhu H. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010; 95(10):4584-4591.
38. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, Wenger J, Karumanchi SA, Thadhani R, Bhan I. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011; 26(7):1609-1616.
39. Johnsen MS, Grimnes G, Figenschau Y, Torjesen PA, Alm as B, Jorde R. Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D [published correction appears in Scand J Clin Lab Invest. 2014; 74(5):464]. Scand J Clin Lab Invest. 2014; 74(3):177-183.
40. Arnaud J, Constans J. Affinity differences for vitaminDmetabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993; 92(2):183-188.
41. Nimitphong H, Saetung S, Chanprasertyotin S, Chailurkit LO, Ongphiphadhanakul B. Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2supplementation. Nutr J. 2013; 12:39.
42. Nissen J, Vogel U, Ravn-Haren G, Andersen EW, Madsen KH, Nexø BA, Andersen R, Mejborn H, Bjerrum PJ, Rasmussen LB, Wulf HC. Common variants in CYP2R1 and GC genes are both determinants of serum 25-hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin D3-fortified bread and milk during winter in Denmark. Am J Clin Nutr. 2015; 101(1):218-227.
43. Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014; 99(10):E2133-E2137.
44. Didriksen A, Grimnes G, Hutchinson MS, Kjærgaard M, Svartberg J, Joakimsen RM, Jorde R. The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol. 2013; 169(5):559-567.
45. Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol. 2013; 136:195-200.
46. Wright NC, Chen L, Niu J, Neogi T, Javiad K, Nevitt MA, Lewis CE, Curtis JR. Defining physiologically "normal" vitamin D in African Americans. Osteoporos Int. 2012; 23(9):2283-2291.
47. Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab. 2012; 97(11):3989-3995.